Abstract
The human genome project may revolutionize our understanding of many cardiovascular diseases and the medications we use to treat them. Why are there variations in disease severity? What causes disease progression in some individuals but not others? Why are there such dramatic differences in response to some therapeutic agents? The human genome project may soon help us answer these questions for patients with disorders ranging from hypertension to congestive heart failure.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 2-9 |
| Number of pages | 8 |
| Journal | Seminars in Anesthesia, Perioperative Medicine and Pain |
| Volume | 26 |
| Issue number | 1 |
| DOIs | |
| State | Published - Mar 2007 |
Keywords
- Adrenergic receptor
- Cardiomyopathy
- Congestive heart failure
- Haplotype
- Hypertension
- Myocardial infarction
- Single nucleotide polymorphism
- Sudden cardiac death
- β Adrenergic receptor blocker
ASJC Scopus subject areas
- Anesthesiology and Pain Medicine
Fingerprint Dive into the research topics of 'β1 and β2 Adrenergic receptor polymorphisms: their impact on cardiovascular physiology, disease states, and response to therapeutic agents'. Together they form a unique fingerprint.
Cite this
Namath, A., Chen, C., Agrawal, R., & Patterson, A. J. (2007). β1 and β2 Adrenergic receptor polymorphisms: their impact on cardiovascular physiology, disease states, and response to therapeutic agents. Seminars in Anesthesia, Perioperative Medicine and Pain, 26(1), 2-9. https://doi.org/10.1053/j.sane.2006.11.001